Virios Therapeutics, Inc. (NASDAQ:VIRI - Get Free Report)'s share price traded down 2.9% during trading on Tuesday . The stock traded as low as $4.75 and last traded at $4.76. 13,455 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,049,645 shares. The stock had previously closed at $4.90.
Virios Therapeutics Trading Down 1.3%
The company has a 50-day simple moving average of $5.10 and a 200 day simple moving average of $5.34. The company has a market cap of $90.71 million, a P/E ratio of -17.44 and a beta of 1.58.
About Virios Therapeutics
(
Get Free Report)
Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.
Featured Articles
Before you consider Virios Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Virios Therapeutics wasn't on the list.
While Virios Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
